Darby Drug Co., Inc., et al. v. Ives Laboratories, Inc.

Opinion summary

Etalia.ai summary of the majority opinion

The case involved a dispute between Darby Drug Co., Inc. and Ives Laboratories, Inc. over trademark infringement under the Lanham Act. Ives Laboratories manufactured a prescription drug with distinctive blue capsules, which they argued was protected by their trademark due to its unique appearance that identified it as an Ives product in the minds of doctors and pharmacists. Darby Drug Co., along with other defendants, produced generic versions of this drug using similar blue capsules after the patent expired, leading to claims from Ives that such actions constituted unfair competition and misleading representation likely to cause confusion among consumers regarding the source of these drugs. The Supreme Court had to consider whether color alone could serve as a valid basis for trademark protection when associated with functional products like pharmaceuticals.